Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

miR-153 inhibits the migration and the tube formation of endothelial cells by blocking the paracrine of angiopoietin 1 in breast cancer cells
Huichun Liang, Fei Ge, Yuhui Xu, et al.
Angiogenesis (2018) Vol. 21, Iss. 4, pp. 849-860
Open Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

Targeting Angiogenesis in Breast Cancer: Current Evidence and Future Perspectives of Novel Anti-Angiogenic Approaches
Nehad M. Ayoub, Sara K. Jaradat, Kamal M. Al-Shami, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 84
The implications of exosomes in pregnancy: emerging as new diagnostic markers and therapeutics targets
Mehri Ghafourian, Roya Mahdavi, Zahra Akbari Jonoush, et al.
Cell Communication and Signaling (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 76
Unique microRNA Signals in Plasma Exosomes from Pregnancies Complicated by Preeclampsia
Hui Li, Yingshi Ouyang, Elena Sadovsky, et al.
Hypertension (2020) Vol. 75, Iss. 3, pp. 762-771
Open Access | Times Cited: 122
The roles and regulation of the KLF5 transcription factor in cancers
Yao Luo, Ceshi Chen
Cancer Science (2021) Vol. 112, Iss. 6, pp. 2097-2117
Open Access | Times Cited: 94
Angiogenesis in gynecological cancers and the options for anti-angiogenesis therapy
Bahar Yetkin-Arik, Arnoud W. Kastelein, Ingeborg Klaassen, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2020) Vol. 1875, Iss. 1, pp. 188446-188446
Open Access | Times Cited: 67
Breast Cancer Drug Resistance: Overcoming the Challenge by Capitalizing on MicroRNA and Tumor Microenvironment Interplay
Giulia Cosentino, Ilaria Plantamura, Elda Tagliabue, et al.
Cancers (2021) Vol. 13, Iss. 15, pp. 3691-3691
Open Access | Times Cited: 44
Epigenetic deregulation in breast cancer microenvironment: Implications for tumor progression and therapeutic strategies
Lenka Trnkova, Verona Buociková, Michal Mego, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116559-116559
Open Access | Times Cited: 7
LINC00152 facilitates tumorigenesis in esophageal squamous cell carcinoma via miR-153-3p/FYN axis
Donglei Liu, Min Gao, Kai Wu, et al.
Biomedicine & Pharmacotherapy (2019) Vol. 112, pp. 108654-108654
Open Access | Times Cited: 49
FOXQ1 inhibits breast cancer ferroptosis and progression via the circ_0000643/miR-153/SLC7A11 axis
Xiaojia Huang, Jinna Wu, Yizhuo Wang, et al.
Experimental Cell Research (2023) Vol. 431, Iss. 1, pp. 113737-113737
Closed Access | Times Cited: 14
Exploring the role of exosomal MicroRNAs as potential biomarkers in preeclampsia
Yuping Shan, Bo Hou, Jingli Wang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
miRNA and long non-coding RNA: molecular function and clinical value in breast and ovarian cancers
Konstantina Panoutsopoulou, Margaritis Avgeris, Andreas Scorilas
Expert Review of Molecular Diagnostics (2018) Vol. 18, Iss. 11, pp. 963-979
Closed Access | Times Cited: 45
An update review of deregulated tumor suppressive microRNAs and their contribution in various molecular subtypes of breast cancer
Narges Dastmalchi, Reza Safaralizadeh, Behzad Baradaran, et al.
Gene (2019) Vol. 729, pp. 144301-144301
Closed Access | Times Cited: 37
MicroRNAs: Important Players in Breast Cancer Angiogenesis and Therapeutic Targets
Bashdar Mahmud Hussen, Sara Tharwat Abdullah, Mohammed Fatih Rasul, et al.
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 28
Glyoxalase I Inhibitors Targeting Breast Cancer-Associated Endothelial Cells: An Integrated Network Pharmacology and Experimental Investigation
Honglin Jiang, Lu Yang, Qiuyue Sun, et al.
Journal of Molecular Structure (2025), pp. 141868-141868
Closed Access
Extracellular Vesicles and Pregnancy-Related Hypertensive Disorders: A Descriptive Review on the Possible Implications “From Bench to Bedside”
Elena Grossini, Daniela Surico, Sakthipriyan Venkatesan, et al.
Biology (2025) Vol. 14, Iss. 3, pp. 240-240
Open Access
Three dimensional engineered models to study hypoxia biology in breast cancer
Vaishali Aggarwal, Oshin Miranda, Paul A. Johnston, et al.
Cancer Letters (2020) Vol. 490, pp. 124-142
Open Access | Times Cited: 29
MicroRNA-153-5p promotes the proliferation and metastasis of renal cell carcinoma via direct targeting of AGO1
Zeyan Li, Shuo Zhao, Shiqin Zhu, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 25
A comprehensive review on miR-153: Mechanistic and controversial roles of miR-153 in tumorigenicity of cancer cells
Saghar Yousefnia
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 16
microRNAs: critical targets for treating rheumatoid arthritis angiogenesis
Lingyun Zhao, Qingze Wu, Yiying Long, et al.
Journal of drug targeting (2023) Vol. 32, Iss. 1, pp. 1-20
Closed Access | Times Cited: 9
RETRACTED ARTICLE: Yap-Hippo pathway regulates cerebral hypoxia-reoxygenation injury in neuroblastoma N2a cells via inhibiting ROCK1/F-actin/mitochondrial fission pathways
Chizi Geng, Jianchao Wei, Chengsi Wu
Acta Neurologica Belgica (2018) Vol. 120, Iss. 4, pp. 879-892
Closed Access | Times Cited: 30
The role of E3 ubiquitin ligase HECTD3 in cancer and beyond
Qiuyun Jiang, Fubing Li, Zhuo Cheng, et al.
Cellular and Molecular Life Sciences (2019) Vol. 77, Iss. 8, pp. 1483-1495
Closed Access | Times Cited: 27
Inhibition of miR-153 ameliorates ischemia/reperfusion-induced cardiomyocytes apoptosis by regulating Nrf2/HO-1 signaling in rats
Wei Hou, Xianting Zhu, Juan Liu, et al.
BioMedical Engineering OnLine (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 27
Lysyl oxidase and hypoxia-inducible factor 1α: biomarkers of gastric cancer
Yalin Han, Li Chen, Rui Qin, et al.
World Journal of Gastroenterology (2019) Vol. 25, Iss. 15, pp. 1828-1839
Open Access | Times Cited: 23
Long non-coding RNA MAFG-AS1 knockdown blocks malignant progression in breast cancer cells by inactivating JAK2/STAT3 signaling pathway via MAFG-AS1/miR-3196/TFAP2A axis.
Mingxing Ding, Yongqiang Fu, Fangming Guo, et al.
PubMed (2020) Vol. 13, Iss. 10, pp. 2455-2473
Closed Access | Times Cited: 21
Angioregulatory microRNAs in breast cancer: Molecular mechanistic basis and implications for therapeutic strategies
Mohammad Hasan Soheilifar, Nastaran Masoudi-Khoram, Soheil Madadi, et al.
Journal of Advanced Research (2021) Vol. 37, pp. 235-253
Open Access | Times Cited: 20
Page 1 - Next Page

Scroll to top